ANIX Gets New Patent for Breast Cancer Vaccine Technology, Stock Up

Anixa Biosciences (ANIX) shares gained 13% on Wednesday following the announcement that the U.S. Patent and Trademark Office has issued a new patent for its groundbreaking breast cancer vaccine technology.In collaboration with Cleveland Clinic, the company is developing a vaccine to treat and prevent breast cancer in an early-stage study.The new patent expands the scope of immunogenic compositions used in Anixa Biosciences’ breast cancer vaccine. It encompasses methods for immunizing patients against breast ...